Search results
Results from the WOW.Com Content Network
A normal average dose of DOC ranges from 0.2–7.0 mg [19] the former producing threshold effects, and the latter producing extremely strong effects. Onset of the drug is 1–3 hours, peak and plateau at 4–8 hours, and a gradual come down with residual stimulation at 9-20h.
Amphetamine [note 2] (contracted from alpha-methylphenethylamine) is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity; it is also used to treat binge eating disorder in the form of its inactive prodrug lisdexamfetamine.
MDA is a substituted methylenedioxylated phenethylamine and amphetamine derivative. In relation to other phenethylamines and amphetamines, it is the 3,4-methylenedioxy, α-methyl derivative of β-phenylethylamine, the 3,4-methylenedioxy derivative of amphetamine, and the N-desmethyl derivative of MDMA.
Amphetamine base in marketed amphetamine medications drug formula molar mass [note 1] amphetamine base [note 2] amphetamine base in equal doses doses with equal base content [note 3] (g/mol) (percent) (30 mg dose) total base total dextro- levo- dextro- levo- dextroamphetamine sulfate [2] [3] (C 9 H 13 N) 2 •H 2 SO 4
Amphetamine type stimulants can be used in the treatment of narcolepsy, a rare neurological disorder where the brain is unable to regulate the sleep-wake mechanism. [17] Amphetamines causes an increase in dopamine release, which is the proposed mechanism for its wake-promoting effect. [ 18 ]
2,5-Dimethoxy-4-iodoamphetamine (DOI) is a psychedelic drug of the amphetamine and 4-substituted-2,5-dimethoxyamphetamine (DOx) families. [3] [4] It is relatively little-used as a recreational drug but is frequently used in scientific research in the study of psychedelics and serotonin receptors.
The text of the Convention does not contain a formal description of the features of the substances fitting in each Schedule, in contrast to the US Controlled Substances Act of 1970, which gave specific criteria for each Schedule in the US system. The amphetamine-type stimulants (ATS), a legal class of stimulants – not all of which are ...
Amfetaminil (also known as amphetaminil, N-cyanobenzylamphetamine, [1] and AN-1; brand name Aponeuron) is a stimulant drug derived from amphetamine, which was developed in the 1970s and used for the treatment of obesity, [2] ADHD, [3] [4] and narcolepsy. [5] It has largely been withdrawn from clinical use following problems with abuse. [6]